LOTEPREDNOL ETABONATE News
LOTEPREDNOL ETABONATE currently has 0 news articles, with 23 predicted indications.
This page combines the AI-predicted indications for LOTEPREDNOL ETABONATE with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (23):
- iritis (disease) (99.0%)
- infectious anterior uveitis (99.0%)
- panuveitis (disease) (99.0%)
- vernal conjunctivitis (99.0%)
- idiopathic uveitis (99.0%)
- punctate epithelial keratoconjunctivitis (99.0%)
- iridocyclitis (disease) (99.0%)
- ciliary body disease (99.0%)
- atopic conjunctivitis (99.0%)
- uveitis (99.0%)
- iris disease (99.0%)
- rosacea (99.0%)
- papillary conjunctivitis (99.0%)
- serous conjunctivitis except viral (99.7%)
- conjunctival folliculosis (99.7%)
- chronic follicular conjunctivitis (99.7%)
- parasitic conjunctivitis (99.7%)
- pseudomembranous conjunctivitis (99.7%)
- Angelucci syndrome (99.7%)
- acute hemorrhagic conjunctivitis (99.6%)
- rosacea conjunctivitis (99.3%)
- acute contagious conjunctivitis (99.3%)
- otitis externa (99.1%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.